Clinical Trial Update: Go-CHOP in de Novo Intestinal T-cell Lymphoma Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Go-CHOP in de novo intestinal T-cell lymphoma (Enteropathy-associated T-cell lymphoma) is listed as not yet recruiting at Ru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Enteropathy-associated T-cell Lymphoma

Drugs mentioned

• Go-CHOP

Snippet

Sponsor: Ruijin Hospital | Conditions: Enteropathy Associated T Cell Lymphoma | Phase 2 | Status: NOT_YET_RECRUITING